Bacteria that can defeat current antibiotic drugs are sometimes called “the next pandemic.” Already, infections from them are believed to cause or contribute to more …

PATH is advancing a portfolio of novel rapid tests for G6PD deficiency that are low cost, simple to use, and meet specifications to improve treatment …